tm
Seeing Is Believing
tm
Seeing Is Believing
GANX is currently covered by 4 analysts with an average price target of $8. This is a potential upside of $5.05 (292.16%) from yesterday's end of day stock price of $2.04.
Gain Therapeutics's activity chart (see below) currently has 46 price targets and 56 ratings on display. The stock rating distribution of GANX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 6.41% with an average time for these price targets to be met of 23.38 days.
Highest price target for GANX is $10, Lowest price target is $5, average price target is $8.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Jul-2026. First documented stock forecast 12-Apr-2021.
Currently out of the existing stock ratings of GANX, 11 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Mar-2022
$8
$5.88 (277.36%)
$8
Buy Since 12-Apr-2021
$5
$2.88 (135.85%)
$9
Buy Since 05-Dec-2024
$10
$8.25 (471.43%)
$6
Buy Since 12-Sep-2023
$7
$5.25 (300.00%)
Buy Since 09-Dec-2022
$6
$4.25 (242.86%)
$6
What is GANX (Gain Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GANX (Gain Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GANX (Gain Therapeutics)?
Which analyst is the currently most bullish on GANX (Gain Therapeutics)?
Which analyst is the currently most reserved on GANX (Gain Therapeutics)?
